| Description: |
Fatty acid binding protein is one of a group of lowmolecular
weight proteins involved in the solubilization
and transport of fatty acids. The release of cytoplasmic
heart fatty acid-binding protein (H-FABP) into the plasma
of cardiac patients is used as a marker of cardiac
damage. In 18 out of 22 patients with established AMI
the plasma FABP level was at or above the threshold
level in blood-samples taken within 3.5 hours after the
first onset of symptoms of AMI, which compares very
favourably with more established markers such as CKMB.
RANDOX recombinant human FABP is expressed in E.
coli with an amino-terminal hexahistidine tag. This
product is for research use only and is not intended for
diagnostic or therapeutic use.
|
| Form:
|
Liquid.
Supplied in 1x Laemmli Buffer (25mM Tris-HCl pH6.8, 50mM
DTT,
1%(w/v) SDS, 0.1%(w/v) Bromophenol Blue, 2.5% Glycerol).
|
| Molecular:
|
19.3kDa
|
| Purity:
|
Single band on Western blot
|
| References:
|
Furuhashi, M. et al. (2003) Nephron Clin Pract. 93(2):
C69-74.
|
| Datasheet: |
|
